FRZB rs7775: Understanding This Genetic Variant
The rs7775 variant is a single nucleotide polymorphism located within the FRZB gene. It is frequently studied in the context of population-specific genetic architecture and various complex traits.
What each genotype means
Typical genetic profile
This genotype represents the common reference sequence for this variant. Research into the association between this variant and osteoarthritis has yielded mixed results, with some studies suggesting a potential link to hip osteoarthritis in females while others have not found significant evidence. This finding should not be used to predict health outcomes or diagnose conditions.
This is the most common genotype observed in most global populations.
Potential susceptibility variant
This genotype involves an arginine-to-glycine (R324G) substitution in the FRZB protein. While some early research explored a potential association with hip osteoarthritis in women, subsequent large-scale meta-analyses have not consistently supported a significant clinical link. This variant is considered a subject of ongoing research rather than a definitive indicator of disease risk.
This heterozygous genotype is found in a significant portion of the population, with a global minor allele frequency of approximately 11%.
Potential susceptibility variant
This genotype results in the presence of the variant allele on both chromosomes, leading to the R324G amino acid change in the FRZB protein. Scientific literature regarding its role in osteoarthritis susceptibility is conflicting, and it is not currently used as a reliable clinical predictor for joint health. Please consult with a healthcare professional if you have concerns about joint pain or mobility.
This homozygous genotype is less common than the reference or heterozygous states in most populations.
What is rs7775 and where is it located?
The rs7775 variant is a single nucleotide polymorphism (SNP) situated on chromosome 2. Specifically, it is located within the FRZB gene, which encodes the Frizzled-related protein. This protein acts as a soluble antagonist of Wnt signaling, a pathway essential for cell-to-cell communication during development and tissue homeostasis. Because rs7775 is located within a gene that plays a regulatory role in skeletal and cellular development, researchers have long been interested in how variations at this site might influence biological processes. SNPs like rs7775 represent the most common type of genetic variation among people, where a single building block of DNA—a nucleotide—is replaced by another. In the case of rs7775, the variation involves the substitution of specific bases, which can be identified through standard genomic sequencing techniques.
The role of the FRZB gene
The FRZB gene provides instructions for making a protein that modulates the Wnt signaling pathway. By binding to Wnt proteins, the FRZB protein prevents them from interacting with their cell-surface receptors, effectively turning down the signaling activity. This mechanism is crucial for the proper formation and maintenance of cartilage and bone tissue. Because Wnt signaling is involved in a wide array of physiological processes, including cell proliferation and differentiation, variations in genes that regulate this pathway are often investigated for their potential impact on structural health. While the FRZB protein is primarily recognized for its role in skeletal development, its influence on cellular signaling means that researchers often look at this gene when studying conditions related to tissue growth and maintenance.
Research associations and evidence strength
The evidence linking rs7775 to specific clinical outcomes is considered moderate. In the scientific literature, rs7775 has been included in various studies exploring population-specific genetic architecture. While some early research suggested potential associations with skeletal traits, these findings are often complex and can vary significantly between different ancestral groups. It is important to note that a statistical association in a genome-wide association study (GWAS) does not imply a direct cause-and-effect relationship. Many factors, including environmental influences and other genetic variants, contribute to the traits being studied. Consequently, the scientific community views rs7775 as a marker of interest rather than a definitive predictor of health outcomes. As with many common variants, the clinical significance remains an area of ongoing investigation rather than established medical fact.
Population frequency
The rs7775 variant is classified as a common SNP, meaning it is found at a relatively high frequency across diverse human populations. Because it is common, it is frequently observed in large-scale genomic databases and population studies. The distribution of the G and other potential alleles can vary by ancestry, which is why researchers often emphasize the importance of considering population background when interpreting genetic data. Understanding the frequency of this variant helps scientists distinguish between rare mutations that might have significant clinical impact and common variations that contribute to the natural diversity of the human genome. For most individuals, carrying a common variant like rs7775 is a normal part of their genetic makeup.
What you can and cannot do with this information
Information about your genotype for rs7775 is for educational purposes only and should not be used to make medical decisions. Genetic variants are only one piece of a much larger puzzle that includes your lifestyle, environment, and overall health history. You cannot use this information to diagnose a condition or predict a specific health outcome. If you have concerns about your health or are interested in how your genetics might influence your well-being, the best course of action is to consult with a qualified healthcare provider or a genetic counselor. They can help you interpret your results in the context of your personal health history and provide guidance based on established clinical standards. Always avoid making changes to your health regimen based solely on information found in genetic databases.
How common is this variant?
The rs7775 variant is a common SNP found across diverse global populations, with its specific genotype frequencies varying by ancestral background.
Frequently asked questions
Is rs7775 a dangerous genetic mutation?
No, rs7775 is a common genetic variant, not a rare or dangerous mutation. It is part of the natural genetic diversity found in human populations.
Can I use my rs7775 result to predict my health?
No, you cannot use this result to predict your health. Genetic variants like rs7775 are complex and influenced by many other factors, including your environment and lifestyle.
Where can I find more information about the FRZB gene?
You can find reliable information about the FRZB gene and its functions on resources like MedlinePlus Genetics or the NCBI Gene database.
Should I talk to my doctor about my rs7775 genotype?
Generally, there is no clinical need to discuss common variants like rs7775 with your doctor unless you have specific health concerns. If you are curious, you can mention it during a routine check-up, but it is unlikely to change your medical care.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7775?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This SNP acts as an intermediate allele tag for the C9orf72 repeat expansion, which is linked to both ALS risk and longevity outcomes.
This variant in the CDKN2B-AS1 long noncoding RNA gene is associated with extreme longevity in genome-wide association studies.
This variant has been identified as a shared genetic signal between longevity and Alzheimer's disease risk.
A variant in the ALOX5 gene associated with potential modulation of inflammatory responses to dietary factors.
This SNP is linked to cardiovascular disease prevention strategies and personalized nutritional approaches.
This polymorphism in the arachidonate 5-lipoxygenase gene is investigated for its potential influence on cardiovascular disease risk and dietary response.